Stock Performance - Akso Health Group's stock price experienced significant fluctuations in January 2026, with a drop of 5.49% on January 3, a decline of 6.25% on January 6, and an increase of 7.52% on January 9. The trading volume and turnover rate were generally low, indicating limited market participation [1]. Financial Performance - As of January 2026, the company's latest financial report shows revenue of $14.8 million, a net loss of $135 million, earnings per share of -$0.47, and a negative gross margin. Currently, no institutions have issued rating recommendations for the stock [2]. Industry Policy and Environment - The medical sales industry, to which the company belongs, showed minimal overall volatility in January 2026, with price fluctuations within ±1.5%. However, there was significant differentiation among individual stocks. The company's business relies on medical device sales, which are heavily influenced by policies, demand, and competition [3]. Future Development - The company's ongoing losses and weak profitability may affect investor confidence. Additionally, low liquidity could amplify stock price volatility risks [4].
Akso Health Group近期股价波动显著 业绩持续亏损